Modeling of heart rate variability and respiratory muscle activity in organophosphate poisoned patients by Salazar, Maria Bernarda et al.
 1 
 Abstract—We propose an extended model of cardiovascular 
regulation to assess heart rate variability in patients poisoned with 
organophosphate during their treatment with mechanical 
ventilation. The model was modified to fit a population of twenty-
one (21) patients poisoned with organophosphorus compounds 
and undergoing mechanical ventilation. The extended model 
incorporated the respiratory muscle activity measured by surface 
electromyography for quantifying the vagal - sympathetic 
engagement during spontaneous breathing test. The order and 
structure of the parasympathetic and the sympathetic transfer 
function with respect to the original model were modified to a 
second - order system. In this extended model, the parameters 
related to the vagal - sympathetic response (corner frequency and 
constant gain) were correlated with respiratory muscle activity. 
When the diaphragm’s contractions were stronger, the 
sympathetic corner frequency increased while the 
parasympathetic corner frequency and gain decreased. Thus the 
proposed model could be useful to improve the ventilatory support 
and pharmacological treatment for patients poisoned with 
organophosphorus compounds considering the vagal - 
sympathetic response inferred from the respiratory muscle 
activity.  
 
Index Terms— Heart rate variability, organophosphate 
poisoning, parasympathetic system, sympathetic system, surface 




he cardiac activity and parasympathetic – sympathetic 
balance is assessed with the Heart Rate Variability (HRV) 
[1], measured during a time interval using non-invasive 
techniques. The cardiac contraction force and heartbeat speed 
are regulated by the Autonomic Nervous System (ANS), with 
mediation of the parasympathetic (PNS) and the sympathetic 
(SNS) nervous system. The periodic component of HRV ranges 
from 0.04 to 0.4 Hz, where the high frequency (HF) range (0.15 
to 0.4 Hz) is mediated by the PNS [2], [3], and the low 
frequency (LF) range (0.04 to 0.15 Hz) is generally mediated 
both by sympathetic and parasympathetic actions [2]. These 
systems usually have opposite effects on the body, the SNS 
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activates the fight-or-flight response, increases heart rate (HR) 
and sweating, dilates bronchi and pupils, and its fibers reach 
almost all organs and systems of the body [4]. On the contrary, 
the PNS is responsible for the body’s resting state, internal 
organ regulation, and digestion. This system decreases HR, 
contracts bronchi and pupils, and  helps maintain an equilibrium 
state of the body [4]. 
Organophosphate (OP) poisoning acts directly on the ANS 
and its action mechanism involves the inhibition of 
acetylcholinesterase enzymes (AChE), which breaks down 
acetylcholine (ACh) at cholinergic synapses [5]. The ACh is a 
neurotransmitter released by the terminal nerve endings of all 
postganglionic parasympathetic nerves and in both sympathetic 
and parasympathetic ganglia [5]. Severe OP poisoning is 
typically characterized by bronchospasms, hypotension or 
hypertension, salivation, pinpoint pupils, agitation, confusion, 
bradycardia or tachycardia, excessive sweating, respiratory 
failure, and coma [6]. Respiratory failure can be attributed to 
dysfunction of neuromuscular junctions, which is associated 
with muscle weakness and muscle paralysis [5] (The action 
mechanism of the OP is given in the Appendix). It is estimated 
that one third of all cases of OP poisoning requires mechanical 
ventilation [7]. To withdrawal ventilatory support (weaning), it 
is necessary to assess not only the respiratory muscle activity 
but also the cardiorespiratory condition of the patient during 
spontaneous breathing test (SBT).  
The importance of measuring the heart rate variability is 
undeniable [8], [9], usually the HRV is performed to analyze 
drug administration effects [10] and as a diagnostic tool for 
diseases such as post-myocardial infarction [11], [12] and risk 
of sudden death [13]. There are reports using HRV as a 
predictor of successful SBT in non-intoxicated patients 
[14], [15], but they do not take into account quantitative 
information about respiratory muscle activity nor about the 
SNS or PNS action to evaluate the inability of the main 
muscle to support the load associated with spontaneous 
breathing. 
There are mathematical models that characterize the 
cardiorespiratory mechanism incorporating the autonomic 
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control system during rest, sleep, exercise or hypercapnia 
conditions [16], [17]. These are useful tools to understand the 
SNS and PNS engagement but they do not allow quantifying 
the magnitude of the action or effects of drugs or toxins on each 
one. Thus, in this article, we present an extended model of 
cardiovascular regulation for assessing the HRV during SBT in 
patients poisoned with OP, considering quantification of the 
sympathetic - vagal engagement. The objective of our study 
was to model the HRV including the respiratory muscle activity 
through the sympathetic - vagal parameters in poisoned 
patients, using biopotentials of the diaphragm and 
sternocleidomastoid muscles. Understanding the sympathetic – 
vagal balance and estimating the magnitude of its action would 
allow addressing pharmacological treatment through the 
patient's physiological response measured non-invasively. 
II. POPULATIONS AND EXPERIMENTAL DESIGN 
A. Patient group 
A database of twenty-one patients (17 men, 4 women; age 
30.0 ± 11.8 years, weight 64.3 ± 9.0 kg, height 165.3 ± 9.0 cm) 
with organophosphorus poisoning was used. Patients were 
included in the study according to the following inclusion 
criteria: i) intoxication with OP, ii) undergoing mechanical 
ventilation, iii) absence of myopathy and thoracic trauma, iv) 
older than 16, and v) not pregnant. 
This study was conducted under the approval of the Ethical 
Review Committee of the San Vicente Fundación Hospital and 
written informed consent was obtained from the patient’s 
family for the publication of this study. 
B. Cardiac, respiratory and surface electromyographic 
signals 
Three-lead electrocardiographic (ECG) signals and 
electromyographic activity were recorded using a biopotential 
amplifier (Bagnoli EMG system, Delsys, Massachusetts, 
United States), coupled to an acquisition card (NI USB 6212) 
configured with a sampling frequency of 1024 Hz. Surface 
electrodes were located in a bipolar configuration for each 
respiratory muscle of interest in the following positions: (a) 
right activity of the diaphragm  was recorded between the 
seventh and eighth intercostal space, on the line located in the 
middle of the mid axillary line and the external clavicular line 
[18], [19]; (b) for the sternocleidomastoid muscle, electrodes 
were placed at 20 % of the distance between the mastoid 
apophysis and the sternal notch and over the line that connects 
them [18]. 
The ventilatory signals (tidal volume, air flow and respiratory 
rate) were recorded with a HAMILTON-S1 ventilator 
(Hamilton Medical, Bonaduz, Switzerland). 
C. Study design 
The study consisted in measuring the HRV and respiratory 
muscle activity while assessing the patient's ability to breathe 
(SBT) receiving minimal ventilation support for 20 min, with 
patients in supine position and the bed head elevated at least 35 
degrees. The start of SBT was defined by clinical expertise 
based on ventilatory signal measurements used as classical 
predictors (e.g., rapid shallow breathing - RSB), but always 
assessing the absence of any of the following previous 
conditions: (i) respiratory rate lower than 8 breaths/min or 
higher than 35 breaths/min for 5 minutes or longer; (ii) 
hypoxemia (oxygen saturation measured by blood analysis 
lower than 88 % for 5 minutes or longer); (iii) sudden changes 
in mental status; (iv) cardiac arrhythmia, and (v) two or more 
symptoms of respiratory distress such as bradycardia (lower 
than 60 beats/min), tachycardia (higher than 130 beats/min), 
paradoxical breathing, diaphoresis or dyspnea.  
III. METHOD 
A. Structured Model 
This study was founded on the model proposed by Saul et al. 
in 1991 [17]. The structured of the original model (Model I) is 
schematically shown in Fig. 1. The Model I studies HR 
regulation and systemic blood pressure through a feedback 
control system that includes the action of arterial baroreceptors. 
The breathing is represented by volume or airflow which 
generates fluctuations in the arterial blood pressure (ABP), this 
vital process is attributed to changes in pressure and volume of 
the chest.  
 
 
The mechanical effects of respiration are modeled as a  
respiration derivative [17]. The properties of the arterial 
vasculature and heart ventricles are modeled as a constant Kv in 
series with a fixed delay Tv [17], which represents the influence 
of the pulse duration on stroke volume [20]. The baroreflex 
control (constant Kb and delay Tb) acts directly on the HR and 
is linked both to the parasympathetic and the sympathetic 
control as a simple summation with weight factors, Ap and As, 
respectively. Saul et al. characterized the contribution of these 
systems in healthy subjects under pharmacological blocked 
conditions and changes in posture. They modeled the 
parasympathetic and sympathetic system as first-order low-pass 
filters with corner frequencies (fp, fs) and constant gains (Kp, 
Fig. 1.  (Model I) Model of closed-loop cardiovascular regulation published by 
Saul et al. [17]. Constant Kb and delay Tb of the Baroreptors; Constant Kv and 
delay Tv of the ventricles and vasculature; The parasympathetic and sympathetic 
system is a first-order low-pass filters with corner frequencies (fp, fs) and 
constant gains (Ap, Kp, Ks, As) and a delay Ts to mimic latency in the sympathetic 
response. 
 3 
Ks) [17], in which the sum effects increase HR during 
inspiration and decrease HR during expiration in a healthy 
subject [20], recreating the dynamics of the sinoatrial (SA) 
node. The authors consider a delay Ts to mimic latency in the 
sympathetic response. 
In this study, we propose to modify the order and structure of 
the parasympathetic and sympathetic transfer functions and the 
weight factors of baroreflex control (see Fig. 2), since according 
to experimental results, a first-order system was not enough to 




B. Identification process 
Breathing induces heart rate fluctuations, although the effect 
in poisoned patients is unknown. The model fitted for healthy 
subjects by Saul et al. [17] requires changes in structure and 
parameter values to be fitted to this population according to a 
preliminary test. The identification process was carried out in 
the frequency domain to characterize the effect in the HRV 
using the cost function represented in (1). The optimization 
process involved the model parameters adjustment to 
experimental data (see Fig. 3) and the identification of the 
system from a set of candidate models [21], [22] (transfers 
functions with different order, from 1 to 5) for the 
parasympathetic and the sympathetic system. 
The cost function measures differences between simulated 
(SIM) and experimental (EXP) data in frequency, as follows: 









































Where |𝐻𝐻(𝑤𝑤𝑘𝑘)| and 𝜑𝜑(𝑤𝑤𝑘𝑘) represent magnitude and phase, 
respectively, and k is the sample number. 
Being 𝐻𝐻(𝑤𝑤𝑘𝑘) the transfer function in the frequency domain, 








wH =  (2) 
Where uyS  is the cross-spectrum between input (u) – output 
(y) and uuS  is the power spectrum of the input (auto-spectrum). 
The optimization was performed by minimizing 𝐽𝐽 in function 
of eight parameters (for order 2 structure), which define the 
parasympathetic and sympathetic response in the Model II (see 
Fig. 2). 
( )sssspppp fAKfAKJJ ξξ ,,,,,,,=  (3) 
The implementation of this controller was carried out by 
Sequential Quadratic Programing (SQP) [23]–[25], using 
Matlab. This technique allowed minimizing the scalar function 
J  within a region specified by constraints and bounds. In order 
to guarantee results with physiological sense, the searching 
space for },,,,,,,{ sssspppp fAKfAK ξξ  was defined within 
the range reported by other authors [17], [20]. The damping 
constants was optimized between: 
〉<<〈〉<<〈 10,10 sp ξξ  (4) 
Being SQP a deterministic algorithm, it could be potentially 
sensitive to the seeds; these were randomly generated with 
uniform distributions. When a premature convergence to a local 
minimum was presented, an automatic random re-initialization 
was applied to improve the reached solution, if it was possible 
[23]. Finally, the optimization process was performed 40 times 
in each case (see Fig. 3) to guarantee the optimization 





With the aim of statistically comparing the fitness of the 
Fig. 2.  (Model II) Model of closed-loop cardiovascular regulation proposing 
that respiration induces heart rate fluctuations. This scheme considers the model 
published by Saul et al. [17] and the changes proposed in this article are 
enclosed by dashed boxes. The parasympathetic and sympathetic system is a 
second-order low-pass filters with corner frequencies (fp, fs), constant gains (Ap, 
Kp, Ks, As), a delay Ts to mimic latency in the sympathetic response and the 
damping constants 𝜉𝜉𝑝𝑝 and 𝜉𝜉𝑠𝑠. 
 
Fig. 3.  Flowchart of the optimization process implemented to identify the 
parameter values of the second order heart rate variability model. 
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model and the mathematical relationship between the 
parameters and sEMG variables, the Wilcoxon Mann Whitney 
nonparametric test was applied with a significant level of α = 
0.05.  
To guarantee the reproducibility of the results, the parameters 
without a clear relationship with sEMG variables were set in 
median of random value of the probability distribution function 
(obtained in the optimization phase), this process was carried 
out 40 times per patient.  
IV. INDEXES 
A. Heart Rate Variability 
The spectral power density (PSD) of electrocardiographic 
signals was estimated using the Burg’s method [26], this 
technique models the time series using an autoregressive 
process, where the PSD is estimated from the model [27]. Most 
of the signal power is from 0 to 0.4 Hz. Three main spectral 
components are distinguished in a spectrum calculated from 
short term recordings (2 to 5 minutes): Very Low Frequency 
(VLF), Low Frequency (LF) and High Frequency (HF) 
components, the frequency ranges are shown in Table I. 
 
 
B. Muscular variables 
The root mean square (RMS) value is used as a measurement 
associated with the signal’s amplitude [28]. In this study, the 
ratio between inspiratory and expiratory RMS values (RMSi/e) 
is an indicator of the muscle fiber activation. RMSi/e achieved 
values higher than one when the muscle was active asumming 
that the muscle relaxed during expiration. The ratio was 

























Where N is the sample number in the half-cycle.  
The engagement between respiratory muscles was evaluated 
using the squared Pearson correlation coefficient between the 
rectified sEMG (Env) of the diaphragm (Dia) and 





















Where C is the covariance matrix. 
This coefficient, 2
, StrnDia
r , weighs the synchronism 
importance between implied respiratory muscles during 
ventilation. When contractions are synchronous, it means that 
both main and accessory respiratory muscles work together to 
support spontaneous breathing.  
In all cases, the patients drank an unknown amount of 
organophosphorus pesticide during a suicidal attempt. On 
admission, gastric lavage was performed and activated charcoal 
was given promptly. During the spontaneous breathing test, 
patients had the heart rate in a range of 65 – 120 beats per 
minute, the respiratory frequency between 10 – 24 breaths per 
minute and the tidal volume (VT) between 0.32 – 0.8 liters. 
These ranges represent a high dispersion of the cardiac and 
ventilatory response in the study population. The VT shows the 
random nature of the spontaneous breathing (see Fig. 4), its 
frequency content reflects that the highest energy is in the HF 
band and occurs in the mean respiratory rate. The power 
spectral density of HR has an inverse distribution compared to 
the respiratory signal distribution: greater peak in the LF than 
in the HF band. 
 
Those parameters with low variance among patients were As, 
𝜉𝜉𝑝𝑝, and 𝜉𝜉𝑠𝑠, which mean and standard deviation values were 26 
± 1.3, 0.9 ± 0.08 and 0.89 ± 0.10, respectively. Its deviations 
are very low compared to the mean value, i.e. their optimal 
value is similar for most patients. Although the searching space 
was extended, this result remained, so that it could be inferred 
that the mean value for these parameters are a global minimum. 
TABLE I 
PARAMETERS IN THE FREQUENCY DOMAIN [32]. 
Variable Description Frequency Range (Hz)) 
Total power (ms2) Power density in all 
frequency range 
0.04 - 0.4 
VLF power (ms2) Total power density  ≤ 0.04 
LF power (ms2) Total power density  0.04 - 0.15 
LF power 
normalized (%) 
LF power / (Total 
power – VLF power) × 
100 
0.04 - 0.15 
LF peak (Hz) Peak Frequency  0.04 - 0.15 
HF power (ms2) Total power density  0.15 - 0.4 
HF power 
normalized (%) 
HF power / (Total 
power – VLF power) × 
100 
0.15 - 0.4 
HF peak (Hz) Peak Frequency 0.15 - 0.4 




Fig. 4.  Representative time series and spectra of tidal volume (Liters, L) and 
heart rate (Beats per minute, bpm). Most of the signals power is in a range of 
0 to 0.5 Hz. The main spectral components are Low Frequency (LF band, 0.04 
- 0.15 Hz) and High Frequency (HF band, 0.15 - 0.4 Hz) components. PSD: 
power spectral density.  
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The relationship between optimal parameters and 
electromyographic activity in patients poisoned with OP was 
explored both in the temporal and frequency domain. The 
2
, StrnDia
r  represents the grade of linear correlation between Dia 
and Strn on the weaning test, where a low correlation 
coefficient suggests poor engagement between Dia and Strn. 
The ratio between inspiratory and expiratory RMS values, 
RMSi/e (Dia), suggests that the muscle contracts during 
inspiration when RMSi/e is greater than 1. 
The Fig. 5 shows the strength of the relationship among 
muscle activity and model parameters as follows: (i) 2
, StrnDia
r - 
fp, (ii) RMSi/e (Dia) - Ap and (iii) RMSi/e (Dia) - fs. Fig. 5.A 
shows that when the diaphragm contractions are stronger, 
according to increases of RMSi/e, the sympathetic frequency 
increases. An opposite behavior is shown in Fig. 5.B, showing 
that the Ap decreases when RMSi/e (Dia) increases; and the 
parasympathetic frequency, fp, decreases when the 
synchronism between respiratory muscles, 2
, StrnDia
r , increases 
(see Fig. 5.C). The last result suggests that when the patient 
needs to use the main muscle and the accessory respiratory 
muscle simultaneously to support the demand for spontaneous 
breathing, the parasympathetic system decreases its action.  
 
From obtained optimal values in all studied samples, 
parasympathetic transfer function gain, Kp, fits a Kernel 
distribution (Fig. 6.A), this produces a nonparametric 
probability density estimate [30] that adapts itself to the data 
with Kernel normal and bandwidth equal to 1.5336. 
Sympathetic transfer function gain, Ks, has a normal 
distribution with a mean and standard deviation of 20.21 and 
10.62, respectively (Fig. 6.B).  
 
The frequency response shows differences between the 
sympathetic and parasympathetic system both in magnitude and 
phase during spontaneous breathing. The sympathetic response 
displays a magnitude decrement and a phase delay increment as 
frequency increases, this behavior is more notable above 0.15 
Hz. The parasympathetic heart rate control is characterized by 
a constant magnitude phase delay at frequency from 0 to 0.5 
Hz.  
As a visual reference, the experimental data of one patient is 
compared to HR predictions by simulations models (I and II) in 
Fig. 7. The HR amplitude and frequency variations predicted by 
the model using the tidal volume and electromyographic 
information (Dia and Strn) mimic the characteristics of the 
experimental data. There are small discrepancies in the LF 
band, mainly in the total energy contained in this frequency, 
although, the energy distribution in comparison to the real 
signal is preserved between bands. 
The above suggests that the changes proposed to the original 
model simulates the vagal - sympathetic balance in relation to 
cardiac variability during spontaneous breathing in intoxicated 
patients. This corresponds with the magnitude and phase 
response of the transfer function (in average) because the 
response in the LF band is product of the interaction between 
the parasympathetic and sympathetic system. 
Table II shows the frequency variables calculated from the 
experimental and simulated HR (Model I and II); these 
variables are usually evaluated make a vagal – sympathetic 
balance diagnosis in HR short-term 5-min recordings. Only the 
spectrum’s peaks from LF and HF bands may be used as a 
measure about autonomic modulation of HRV in shorter 
recordings. Its maximum and minimum values are presented in 
each variable as well as the prediction error with respect to 
variables measured for experimental data. 
According to prediction error results, the Model II shows a 
good fit to the population, the total power and its distribution in 
terms of low and high frequency bands has an error lower than 
20%, compared to Model I which has errors greater than 200%. 
For Model II, the most significant error occurs in the HF band, 
 
Fig. 5.  Relationship between optimal parameter (Model II) and 
electromyographic variables. The squared Pearson correlation coefficient (R2) 
between the rectified amplitudes of sEMG for two different muscles: 
diaphragm (Dia) and sternocleidomastoid (Strn) muscles; RMSi/e (Dia): the 
ratio between inspiratory and expiratory RMS values; fp: parasympathetic 
corner frequency; Ap: parasympathetic weight factors of baroreflex control; 
and fs: sympathetic corner frequency. 
 
Fig. 6.  Probability distribution function for the following optimal parameters 
of the Model II: (A) Kernel distribution for Kp (parasympathetic constant 
gain), Kernel normal and bandwidth: 1.5336; (B) Normal distribution for Ks 
(sympathetic constant gain), mean: 20.21 and standard deviation 10.62. 
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which is reflected in the prediction error associated to the 
LF/HF ratio, perhaps because the frequency response of the 
parasympathetic system does not present significant changes in 
magnitude and phase when the respiratory rate rises or falls 




The aim of this study was to model the HRV considering the 
relationship between heart rate dynamics and respiratory 
muscle activity through the sympathetic - vagal parameters in 
poisoned patients. Many studies have shown that power 
spectrum analysis of the heart rate variability provides 
important information about autonomic nervous system activity 
[31], [32]. The starting point of this work was the model 
proposed by Saul et al. in 1991, this model is focused on 
characterizing the respiratory sinus arrhythmia (RSA) in 
healthy subjects [17]. The relationship between RSA and HRV 
can be measured as a variation of the HF band in HR record 
[33]. Therefore, with the purpose of modeling the HRV 
characteristics both in low and high frequency bands, a 
modification in the sympathetic and parasympathetic transfer 
functions has been proposed and validated using experimental 
data. Two parameters were added to the model, 𝜉𝜉𝑝𝑝 and 𝜉𝜉𝑠𝑠, 
corresponding to the damping factor in a second-order system.  
We propose that oscillations, whether part of in LF or HF 
band can be actively compensated for by vagal-sympathetic 
control. This approach has been referred by Piovesan et al. in a 
third-order model to represent the biomechanical properties of 
muscles and tendons [34]. The 𝜉𝜉𝑝𝑝 and 𝜉𝜉𝑠𝑠 may be related with 
future studies with vasodilation and vasoconstriction produced 
by sympathovagal regulation, an important characteristic that 
 
Fig. 7.  Comparison of experimental data and simulation results (Model I and II) of representative time series and spectra of the heart rate (Beats per minute, 
bpm) of a random patient. The main spectral components are Low Frequency (LF band, dark gray, 0.04 - 0.15 Hz) and High Frequency (HF band, light gray, 
0.15 - 0.4 Hz). 
TABLE II 
PREDICTION ERROR IN FREQUENCY DOMAIN CALCULATED IN THE ANALYSIS OF SHORT-TERM RECORDINGS (5 MIN) OF THE HEART RATE SIMULATED WITH THE 
ORIGINAL AND PROPOSED MODELS (I AND II RESPECTIVELY). LOW FREQUENCY (LF BAND, 0.04 - 0.15 HZ) AND HIGH FREQUENCY (HF BAND, 0.15 - 0.4 HZ). 













LF peak (Hz) [0.058, 0.124]  [0.060, 0.140] [3.448, 12.90]  [0.060, 0.124] [0.000, 3.448] 
LF power normalized (%) [65.98, 97.90]  [9.834, 93.38] [4.616, 85.09]  [72.46, 97.75] [0.230, 9.830] 
HF peak (Hz) [0.200, 0.333]  [0.200, 0.400] [0.000, 20.12]  [0.200, 0.400] [0.000, 20.00] 
HF power normalized (%) [2.028, 34.02]  [6.612, 90.16] [164.9, 226.0]  [2.250, 27.53] [10.94, 19.06] 
LF/HF ratio [1.939, 48.31]  [0.109, 14.12] [70.77, 94.37]  [2.632, 43.45] [10.06, 35.70] 
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Saul et al., do not included in the original model and could play 
an important role in poisoned or under pharmacological 
treatment patients. 
The optimal parameters of the first-order low-pass filter [17] 
for the parasympathetic and the sympathetic systems were 
obtained under different conditions for this study (Model I): 
healthy subjects with pharmacological autonomic blockage and 
under posture changes. However, we consider these as 
physiological values but we extended the searching scope in the 
SQP algorithm to analyze if the optimal parameters found after 
minimization would correspond to a local or a global minimum. 
Serna et al. [23] found that the SQP algorithm was more 
efficient in comparison to other algorithms in the prediction of 
pattern changes within a respiratory cycle. 
The definition of the model parameters – Model II – 
considering the patient’s condition is relevant because the HRV 
is influenced not only by factors such as age or gender, but also 
by the physiological state and drug pharmacodynamics [31]. 
Taking into account the relationship between relaxation and 
contraction in muscles that depends on vagal and sympathetic 
action, respectively, the physiological state of the poisoned 
patient can be evaluated through the respiratory muscle activity 
measurement [35]. The muscle activity in the diaphragm and 
sternocleidomastoid muscles were recorded with surface 
electromyography according to previous studies that evaluated 
the activity of muscles involved in breathing during SBT in 
mechanically ventilated patients [36]–[38]. Two variables 
related to muscular activity during SBT in patients poisoned 
with organophosphorus compounds have been presented in this 
paper: the 2
, StrnDia
r  coefficient and the classical RMSi/e ratio. In 
previous studies theses variables have been used as an indicator 
of respiratory muscles activity in a case report [39] and as a 
good measure of the sEMG signal amplitude both in 12 
mechanically ventilated patients [40] and in a population of 23 
patients poisoned with organophosphate [38]. These findings 
show that the RMSi/e (Dia) and 2
, StrnDia
r  have a strong 
relationship with parasympathetic and sympathetic parameters, 
which complements their usefulness in critical patient 
monitoring. Particularly, the results showed two possible 
response patterns, the first one characterized by the presence of 
diaphragm’s weak contractions (RMSi/e ≈ 1) and low 
engagement between the diaphragm and sternocleidomastoid 
muscle ( 2
, StrnDia
r  < 1). These suggest a state of muscle relaxation 
that drives the inability of the main muscle to support the load 
associated with spontaneous breathing. According to the results 
(Model II), patients with these characteristics have the highest 
values of frequency (fp) and gain (Ap) of the parasympathetic 
branch. This pattern agrees with what is known about the 
parasympathetic action: regulates rest functions and it is 
predominant during a quiet state [4]. On the contrary, the 
sympathetic action had a greater relationship with an increase 
in the diaphragm’s activation: fs increases as RMSi/e. Although 
the spontaneous breathing test does not imply physical activity 
such as riding a bicycle, this puts the patient in a stress situation 
because during the gradual withdrawal of ventilatory support, 
he assumes his breath.  
It is possible that the patient presents signs of increased work 
of breathing or distress, therefore requiring the use of the 
accessory muscles. These responses are usually activated by the 
sympathetic system, which prepares the body for the stress 
response [4]. 
During spontaneous breathing test, the patients had an upper 
torso inclination of 35º – 40º. Results published by Kubota et 
al. suggested that slight flexion of the upper torso in Fowler’s 
position activates respiratory function and increases the 
contribution of vagal nerve activity to the cardiovascular 
system [41]. This could explain the low variability of 
sympathetic weight factors of baroreflex control (As). 
The results obtained from the HRV simulation with the 
Model II, including the respiratory muscle activity of the 
diaphragm and sternocleidomastoid muscles are comparable 
with the experimental data, specifically in the frequency 
variables evaluated in the HRV analysis. The increase in time 
between heartbeats implies HR decreases with an 
accompanying increase of HRV. The opposite occurs when the 
HR increases [32]. The values for the frequency variables 
reflects that the HF power corresponds with respiratory activity 
related to the frequency characteristics of heart rate. Mccraty et 
al. [32] suggests that lower HF power is associated with stress, 
panic, anxiety, or worry. This is consistent with our results, 
because the HF band has the lower power normalized in all 
patients. It is known that the SBT causes many distressing 
symptoms, such as: pain, agitation, lack of sleep, and especially 
anxiety [42]. 
The sympathetic system decreases its influence in rhythms 
above 0.15 Hz, while the parasympathetic system is affected 
between 0.04 to 0.4 Hz. Some authors have suggested that the 
LF band reflects sympathetic activity [43], although most 
investigators believe it reflects sympathovagal activity [44], 
[45]. Even though the patients during SBT were not under the 
pharmacological autonomic blocked, 16/21 patients received 
atropine therapy (0.5 – 27 mg) on arrival in the intensive care 
and the effects of atropine may not have disappeared 
completely even six weeks after exposure [46]. Whereby the LF 
power could be related with sympathetic action, taking into 
account the effects the atropine and effort associated with the 
spontaneous breathing test.  
VI. CONCLUSION 
To find a quantitative relationship between respiratory 
muscle activity and the cardiorespiratory response during the 
recovery period of poisoning, through the quantification of 
sympathovagal participation in the cardiac response variability, 
its use could give light in improving the efficiency of 
therapeutic treatments, more specifically in the ventilatory 
strategy. The extended model of cardiovascular regulation 
presented introduces an alternative approach to assess the 
sympathetic – parasympathetic balance through the heart rate 
variability complemented with information about the 
respiratory muscle engagement. The diaphragm and 
sternocleidomastoid activity measured by surface 
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electromyography can reflect and quantify the sympathetic - 
vagal engagement during spontaneous breathing test. This 
model may be used to continuously assess (non-subjective) the 
muscle weakness caused by organophosphates poisoning and 
the clinical state of the sympathetic and parasympathetic system 
(considering the pharmacological treatment) possibly achieving 
a shorter mechanical ventilation time, establishing 
requirements for mechanical support adapted to the daily needs 
of each patient. 
APPENDIX 
In the following link, the GIBIC group shares a 3D animation 
of the action mechanism of the Organophosphorus compounds 
produced during the developing of this thesis: 
https://youtu.be/8R9fNhvkXog. 
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